Westar Energy Inc (WR) is Trading Higher on Unusual Volume for February 03

Equities Staff |

Westar Energy Inc (WR) experienced unusually high volume on Feb. 03, as the stock gained 3.12% to a closing price of $46.40. The stock saw 1.78 million shares trade hands over the course of the day on 18,971 trades. Given that the stock’s average daily volume over the last month has been 929,743 shares a day, this represents a pretty substantial spike over the norm.

Westar Energy Inc has a P/B ratio of 1.79. It also has a P/E ratio of 19.5. The stock has traded between $45.36 and $33.88 over the last 52-weeks, its 50-day SMA is now $41.98, and its 200-day SMA $38.03.

Westar Energy Inc is an electric utility company. It produces, transmits and sells electricity at retail in Kansas and at wholesale in a multi-state region in the central United States under the regulation of the KCC and FERC.

Headquartered in Topeka, KS, Westar Energy Inc has 2,411 employees and is currently under the leadership of CEO Mark A. Ruelle.

For a complete fundamental analysis analysis of Westar Energy Inc, check out Equities.com’s Stock Valuation Analysis report for WR. To see the latest independent stock recommendations from Equities.com’s analysts, visit our Research section.


The Russell 3000 is not well known outside the world of finance, but it’s one of the strongest indices out there for getting a broad sense of the stock market. Unlike the better-known Dow Jones Industrial Average or S&P 500, membership on the Russell 3000 isn’t selected by committee. It’s simply the 3,000 most valuable companies in the country.

With 3,000 stocks making up the index, it gives a broad look at the markets, including the small-and mid-cap companies that aren’t on the Dow or the S&P 500. And with a rules-based system for determining membership, there’s no bias that could potentially limit membership. That’s why many financial professionals will turn to the Russell 3000 long before the better-known indices when trying to take the temperature of the market.

For more news on the financial markets, go to Equities.com. Also, learn more about our independent proprietary equity research reports and our robust do-it-yourself Stock Valuation Analysis reports in our Research section.

All data provided by QuoteMedia and was accurate as of 4:30PM ET.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer


Emerging Growth

Immunovaccine Inc.

Immunovaccine Inc is clinical stage biopharmaceutical company. The Company develops products based on its proprietary vaccine enhancement platform in T cell activating therapies for cancer.

Private Markets

MyForce, Inc.

As parents, we constantly worry about the safety of our loved ones. The media bombards us with incidents from across the nation school shootings, frequent assaults on campuses, and crimes…

Initial State

Initial State is an Internet of Things (IoT) data analytics & data management platform company. We turn sensor and event data into information that matters by making it easy to…